Cell Line Models for Acquired Resistance to First-Line Osimertinib in Lung Cancers—Applications and Limitations

Lignende værker

• Collateral Chemoresistance to Anti-Microtubule Agents in a Lung Cancer Cell Line with Acquired Resistance to Erlotinib
  af: Mizuuchi, Hiroshi, et al.
  Udgivet: (2015)
• Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer
  af: Suda, Kenichi, et al.
  Udgivet: (2015)
• Development of personalized treatments in lung cancer: focusing on the EGFR mutations and beyond
  af: Suda, Kenichi, et al.
  Udgivet: (2013)
• Activity of tarloxotinib‐E in cells with EGFR exon‐20 insertion mutations and mechanisms of acquired resistance
  af: Nishino, Masaya, et al.
  Udgivet: (2021)
• Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations
  af: Suda, Kenichi, et al.
  Udgivet: (2021)